טוען...
Peptide-Targeted Polyglutamic Acid Doxorubicin Conjugates for the Treatment of α(v)β(6)-Positive Cancers
Most chemotherapeutics exert their effects on tumor cells as well as their healthy counterparts, resulting in dose limiting side effects. Cell-specific delivery of therapeutics can increase the therapeutic window for treatment by maintaining the therapeutic efficacy while decreasing the untoward sid...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053474/ https://ncbi.nlm.nih.gov/pubmed/18710273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bc800154f |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|